Emergent BioSolutions (EBS) Minority Interest (2010 - 2013)

Emergent BioSolutions' Minority Interest history runs 4 years deep, the most recent figure standing at -$453000.0 for Q4 2013.

• On a quarterly basis, Minority Interest fell 158.83% year-over-year to -$453000.0 in Q4 2013; TTM through Dec 2013 was -$453000.0, a 158.83% decrease from a year earlier, with the FY2013 full-year figure at -$453000.0, down 158.83% from the prior year.
• Minority Interest fell to -$453000.0 in Q4 2013 per EBS's latest filing, from -$449000.0 in the prior quarter.
• Across five years, Minority Interest topped out at $4.1 million in Q4 2010 and bottomed at -$453000.0 in Q4 2013.
• The 4-year median for Minority Interest is $1.9 million (2011), against an average of $1.7 million.
• Across the five-year window, Minority Interest dropped 28.83% in 2012 and sank 158.83% in 2013, its largest moves.
• Year by year, Minority Interest stood at $4.1 million in 2010, then plunged by 39.44% to $2.5 million in 2011, then sank by 68.96% to $770000.0 in 2012, then sank by 158.83% to -$453000.0 in 2013.
• Per Business Quant, the three latest EBS Minority Interest figures stand at -$453000.0 (Q4 2013), -$449000.0 (Q3 2013), and -$448000.0 (Q2 2013).